Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
SAR408701 + Ramucirumab/Pembrolizumab for Lung Cancer
Recruiting1 awardPhase 2
Detroit, Michigan
This trial is testing a new combination drug therapy for people with non-small cell lung cancer that has progressed despite other treatments. The goal is to see if the new therapy is safe and effective.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.